Wells Fargo & Company Athersys, Inc Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.86 $3,043 - $14,539	-16,906 Reduced 18.89%	72,586 $19,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $41,745 - $73,749	-69,575 Reduced 43.74%	89,492 $55,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $99,488 - $163,863	117,045 Added 278.53%	159,067 $143,000
Q3 2021 Nov 15, 2021	SELL	$1.33 - $1.77 $399 - $531	-300 Reduced 0.71%	42,022 $56,000
Q2 2021 Aug 16, 2021	SELL	$1.41 - $1.94 $26,658 - $36,679	-18,907 Reduced 30.88%	42,322 $61,000
Q1 2021 May 13, 2021	SELL	$1.61 - $2.77 $501,788 - $863,325	-311,670 Reduced 83.58%	61,229 $110,000
Q4 2020 Feb 09, 2021	SELL	$1.55 - $2.24 $97,696 - $141,187	-63,030 Reduced 14.46%	372,899 $654,000
Q3 2020 Nov 05, 2020	SELL	$1.91 - $3.08 $16,362 - $26,386	-8,567 Reduced 1.93%	435,929 $850,000
Q2 2020 Aug 13, 2020	BUY	$1.97 - $3.98 $284,121 - $574,011	144,224 Added 48.03%	444,496 $1.23 Million
Q1 2020 May 14, 2020	BUY	$1.17 - $3.0 $351,318 - $900,816	300,272 New	300,272 $901,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.